TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

10597	Companies
224774	Keywords
153500	Articles
118912	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 03/26/2026 at 17:45, 2 months 23 days ago

Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress
Transgene to present oral session on TG4050, an Individualized Neoantigen Therapeutic Vaccine, at World Vaccine Congress. Phase 1 findings in head and neck cancer and potential in early-stage treatment to be discussed

World Vaccine Congress Vaccine Transgene TG4050 Individualized Neoantigen
BRIEF

published on 01/23/2026 at 08:05, 4 months 26 days ago

Transgene strengthens its scientific committee with two immunotherapy experts.

Immunotherapy Cancer Transgene Antoine Italiano Ignacio Melero
BRIEF

published on 01/23/2026 at 08:05, 4 months 26 days ago

Transgene Enhances Scientific Advisory Board with New Appointments

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
PRESS RELEASE

published on 01/23/2026 at 08:00, 4 months 26 days ago

Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
BRIEF

published on 11/27/2025 at 00:20, 6 months 21 days ago

Transgene: Resumption of Trading on Euronext Paris

Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE

published on 11/27/2025 at 00:15, 6 months 21 days ago

Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets
Transgene resumes trading of shares on Euronext Paris following capital increase results publication

Euronext Paris Shares Trading Capital Increase Transgene
BRIEF

published on 11/26/2025 at 23:37, 6 months 21 days ago

Transgene Raises €105 Million for Cancer Vaccine Development

Biotechnology Fundraising Cancer Vaccines Transgene Myvac® Platform
PRESS RELEASE

published on 11/26/2025 at 23:32, 6 months 21 days ago

Transgene Successfully Completes a Fundraising of c. €105 Million
Transgene successfully completes a fundraising of c. €105 million, enabling acceleration of myvac® program development and extending financial visibility until early 2028

Fundraising Cancer Vaccines Transgene Financial Visibility Myvac® Program
BRIEF

published on 11/25/2025 at 22:06, 6 months 22 days ago

Transgene raises funds with the Talisman project

Euronext Paris Fundraising Transgene Talisman Myvac®
BRIEF

published on 11/25/2025 at 21:47, 6 months 22 days ago

Temporary suspension of trading in Transgene shares

Euronext Paris Biotechnology Capital Increase Transgene Quoting

Accesswire

Published on 06/18/2026 at 18:00, 58 minutes ago

BEACN Closes Second Series Under Loan Program and Previews BEACN App Version 1.4
Published on 06/18/2026 at 17:30, 1 hour 28 minutes ago

Sekur Private Data Appoints Nathan R. Price as Special Advisor for Diplomacy & Intelligence
Published on 06/18/2026 at 15:50, 3 hours 8 minutes ago

Pentagon I Capital Corp. and Prospectiva Resources Ltd. Announce Financing
Published on 06/18/2026 at 15:00, 3 hours 58 minutes ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Published on 06/18/2026 at 14:30, 4 hours 28 minutes ago

Voting Results from Solitario Resources Corp Annual Meeting Held June 17, 2026

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 18:30, 27 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/18/2026 at 18:25, 32 minutes ago

Sopra Steria achives Level 2 Responsible Digital Label and strengthens its responsible digital strategy
Published on 06/18/2026 at 17:45, 1 hour 13 minutes ago

2CRSi SA: 2CRSi disputes the content of the document published by Grizzly Research and is preparing a substantiated response calling for the suspension of trading in its shares
Published on 06/18/2026 at 17:40, 1 hour 17 minutes ago

REINET INVESTMENTS S.C.A. ANNOUNCES SHARE BUYBACK PROGRAMME
Published on 06/18/2026 at 17:36, 1 hour 21 minutes ago

Amundi Physical Metals plc: UK Final Terms

Les Echos

Published on 06/18/2026 at 18:00, 58 minutes ago

Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 1 hour 13 minutes ago

EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 1 hour 19 minutes ago

Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 13:00, 5 hours 58 minutes ago

Edenred statement
Published on 06/18/2026 at 09:06, 9 hours 52 minutes ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany

View all LES ECHOS COMFI WIRE